MarketInOut Stock Screener Log In | Sign Up
 

Biodesix Inc

IEX • Healthcare • Diagnostics & Research • Quote as of 06/26/2026 15:59
Biodesix Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeIEX
Market Capitalization179.67 mln
Float4.47 mln
Earnings Date08/12/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.73
Likely reliable

1-Year Forecast

30.60
Strong upside

Relative Strength

100 / 100
Top performer

Debt / Equity

7.84
Extremely leveraged

ROE

-932
Deeply negative

Business Description

Biodesix is a medical diagnostics company based in Louisville, Colorado, focused on helping doctors detect and manage lung cancer. The company offers blood-based tests that evaluate the likelihood of malignancy in lung nodules and guide treatment decisions by analyzing tumor mutations and immune system activity. Biodesix also supports pharmaceutical and life sciences companies through research, biomarker discovery, clinical trial testing, and regulatory assistance. Founded in 2005, the company has built and operates its own laboratory network to deliver these services.

Key Fundamentals

EPS-3.96
ROE-932
RPS11.84
ROIC-39.06
ROA-35.92
EBITDA, mln-19.75
EV / EBITDA-10.11
EV / EBIT-8.34
Revenue, mln96.10
EV / Revenue2.08

Financial Strength

Altman Z-Score-5.89
Piotroski F-Score 5 / 9
Beneish M-Score-2.73
1-Year Target Price30.60
Short Ratio1.36
Short % of Float1.80

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 37.21% 100 / 100   
1 Month 57.12% 99 / 100   
2 Months 41.63% 91 / 100   
6 Months 245% 99 / 100   
1 Year 331% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us